High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year Period-Reference-Cited by-同舟云学术

High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year Period

Published:2024-07-24 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Umetsu Araya¹,Tanaka Marenao²³,Sato Tatsuya²⁴,Akiyama Yukinori⁵,Endo Keisuke²,Mori Kazuma⁶,Ohnishi Hirofumi²⁷,Watanabe Megumi¹,Ohguro Hiroshi¹,Hanawa Nagisa⁸,Furuhashi Masato²

Affiliation:

1. Department of Ophthalmology, School of Medicine, Sapporo Medical University

2. Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine

3. Tanaka Medical Clinic

4. Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine

5. Department of Neurosurgery, Sapporo Medical University School of Medicine

6. Department of Immunology and Microbiology, National Defense Medical College

7. Department of Public Health, Sapporo Medical University School of Medicine

8. Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-24-0241/_pdf

Reference47 articles.

1. 1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol 2022; 80: 2361–2371.

2. 2. NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398: 957–980.

3. 3. Sato T, Kouzu H, Yano T, Sakuma I, Furuhashi M, Tohse N. Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: A brief overview. Front Cardiovasc Med 2023; 10: 1159953.

4. 4. Ussher JR, Drucker DJ. Glucagon-like peptide 1 receptor agonists: Cardiovascular benefits and mechanisms of action. Nat Rev Cardiol 2023; 20: 463–474.

5. 5. Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J 2023; 44: 2066–2077.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FABP5 Is a Possible Factor for the Maintenance of Functions of Human Non-Pigmented Ciliary Epithelium Cells;International Journal of Molecular Sciences;2024-08-27